Andrew Friedmann, MD
Orthopaedic Surgery · Houston, TXNPI 1467899229
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (38.7%), food and beverage and education — rather than concentrated in one kind of arrangement. Arthrex accounts for 62.2% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $17,399 and has fallen 95.8% since, to $724 in 2025.
Across 154 payments — averaging $167.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$16K
- Stryker$4K
- Medinc Of Texas$4K
- Medshape, Inc.$372
- Heron Therapeutics, Inc.$301
- Paragon 28, Inc.$200
- plus $1K from 15 others
What the payments were for
- Grants$10,00039%
- Travel & lodging$3,47013%
- Food & beverage$7,08827%
- Education$5,30621%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 43 | $16,089 |
| Stryker(2 entities) | 55 | $4,000 |
| Medinc Of Texas | 23 | $3,839 |
| Medshape, Inc. | 2 | $372 |
| Heron Therapeutics, Inc. | 3 | $301 |
| Paragon 28, Inc. | 2 | $200 |
| Exactech, Inc. | 1 | $178 |
| In2bones USA, LLC | 2 | $177 |
| Treace Medical Concepts, Inc. | 3 | $143 |
| Forma Medical | 1 | $140 |
| Johnson & Johnson | 2 | $138 |
| Ossur Americas, Inc. | 6 | $75 |
| Alafair Biosciences, Inc. | 3 | $49 |
| Tricoast Surgical Solutions LLC | 1 | $42 |
| Vericel Corporation | 1 | $23 |
| KCI USA, Inc. | 1 | $21 |
| Innovation Technologies Inc | 1 | $17 |
| Kerecis Limited | 1 | $17 |
| Amgen | 1 | $16 |
| ERMI LLC | 1 | $15 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SALVATION$406
- INFINITY$401
- CITREFIX$292
- Zynrelef$270
- ANCHORAGE$245
- DynaNail Hybrid$225
- VANTAGE$178
- PROPHECY$171
- MAKO$159
- VARIAX$151
- ORTHOLOC 2 LAPIFUSE$150
- AUGMENT INJECTABLE$149
- PROLAYER$149
- DynaClip Bone Fixation System, Quattro, 22mm x 20mm x 20mm$147
- DynaNail Helix, Washer, 15 mm$147
- DynaNail$147
- INFINITY ADAPTIS$142
- OptimalMTP$140
- STAR$132
- Quantum Total Ankle$128
How this compares
$25,864 in reported general payments places this provider in the 80th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 51 | $426 |
| Ondansetron OdtOndansetron | 22 | $224 |
| Meloxicam | 56 | $145 |
| Methylprednisolone | 18 | $115 |
| Tramadol Hcl | 13 | $25 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Houston
- Stefan KreuzerHouston$6.2M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- Adam FreedhandHouston$1.8M
- Jeffrey KozakHouston$1.1M
- Travis HansonHouston$1M
- Thomas TanousHouston$698K
- Alan RechterHouston$605K
- Ugonna IhekweazuHouston$544K
- Darrell HansonHouston$284K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.